The Damning Verdict on Drug Trials

[Guest guest]

Interesting article here, in view of the criticisms that for years

have been leveled at research in China on CM.

 

From The Guardian:

 

http://tinyurl.com/y8ljrco

 

ann

 

 

[Guest guest]

Meaning it's the pot calling the kettle black?

 

The thing about the CM research that is encouraging is that, in the vast

majority of cases (99+%), pharmaceutical companies do not stand to gain

financially from positive outcomes. In my estimation, only 1% or less of Chinese

CM clinical trials involve proprietary meds. The whole motivation for conducting

and publishing research in China is different from in the West. If you track

Chinese research over the last 20 years as I have, you can see great

improvements in study design and statistical analysis. The main difference

between Chinese research today and clinical trials done in the West is the lack

of double-blinding and placebo control. Both of these would be hard to add to

the typical CM clinical trial (for instance, where formulas a modified based on

symptoms) or certainly with acupuncture. While I understand the rationale for

both these elements of Western medical studies, their lack is not necessarily a

deal-breaker for me. They may be " nice-to-haves " but they're not always

" have-to-haves. " In the hierarch of medical research, it's not always wise to

let the perfect be the enemy of the good.